Bromelain, a mixture of proteases extracted from the stem of the pineapple, has been used by Europeans for many years to inhibit inflammatory factors. Bromelain’s fluid-regulating properties may result from its ability to effectively suppress inflammatory cytokine production, inhibit neutrophil migration, and support removal of some cell surface inflammatory molecules. Research also shows that bromelain may help support healthy blood viscosity and blood platelet aggregation.106,107
Bromelain has to be enteric coated so that it will not be activated in the stomach and used as a digestive enzyme. Enteric-coated bromelain tablets pass into the small intestine where they are absorbed into the bloodstream to provide systemic benefits.
Specially coated bromelain may significantly modulate inflammatory reactions in the joints. Research has demonstrated that enteric-coated bromelain formulations are at least as effective as other approaches in supporting joint comfort, function and health and are well tolerated.108-110 One study even found that bromelain is more effective than other methods for maintaining joint function at rest (41% for bromelain versus 23% for other methods).110
Another study showed that specially coated bromelain yielded an overall improvement in general well-being, along with improvement in comfort and physical function.109
| Supplement Facts |
|
Serving Size 1 enteric coated vegetarian tablet
|
| Amount Per Serving |
|
Calcium (as calcium carbonate)
|
75 mg
|
|
Bromelain proteolytic enzyme extract from pineapple (stem) [2400 Gelatin Digestive Units per gram]
|
500 mg
|
|
Other ingredients: microcrystalline cellulose, maltodextrin, enteric coating (methacrylic acid copolymer dispersion NF, hydroxypropyl methylcellulose, propylene glycol), croscarmellose sodium, stearic acid, hydroxypropyl cellulose, silica, vegetable stearate.
|
|
| Dosage and Use |
- Take one (1) tablet once or twice daily on an empty stomach, or as recommended by a healthcare practitioner.
|
| Caution |
|
If you are taking anti-coagulant or anti-platelet medications, or have a bleeding disorder, consult your healthcare provider before taking this product. Bromelain may increase the bioavailability of tetracycline antibiotics.
|
|
Warnings
- KEEP OUT OF REACH OF CHILDREN
- DO NOT EXCEED RECOMMENDED DOSE
- Do not purchase if outer seal is broken or damaged.
- When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.
|
References
|
1. Acta Obstet Gynecol Scand. 1993 Apr;72(3):148-56.
2. Rheum Dis Clin N Am 33 (2007) 149-176
3. Eur J Clin Invest. 1988 Oct;18(5):529-34.
4. Bone. 2001 Mar;28(3):327-31.
5. Endocr Rev. 2011 Feb;32(1):31-63.
6. J Osteoporos. 2011;2011:108324. doi: 10.4061/2011/108324. Epub 2011 Nov 1.
7. J Endocrinol. 2002 Mar;172(3):673-81.
8. Gynecol Obstet Fertil. 2007 Sep;35(9):785-90.
9. J Prosthet Dent. 1995 Jan;73(1):65-72.
10. Am J Clin Nutr. 2000 Sep;72(3):681-9.
11. Clin Calcium. 2006 Oct;16(10):1624-31.
12. J Nutr Elder. 2008;27(1-2):3-27.
13. Calcif Tissue Int. 2011 Feb;88(2):117-29.
14. Clin Ter. 2009;160(2):105-9.
15. Sports Med. 2009;39(6):439-68.
16. J Am Geriatr Soc. 2005 Nov;53(11):1875-80.
17. J Clin Invest. 2006 Dec;116(12):3150-9.
18. Mol Cell Endocrinol. 2011 Dec 5;347(1-2):48-54.
19. Bone Miner. 1994 Dec;27(3):235-47.
20. Biorheology. 2002;39(1-2):237-46.
21. Drugs Aging. 2010 Feb 1;27(2):95-115
22. Magnes Trace Elem. 1990;9(2):61-9.
23. Curr Pharm Des.2003;9(32):2687-704.
24. Ann Nutr Metab. 2002;46(6):249-53.
25. J Int Med Res. 2007 Sep-Oct;35(5):692-5.
26. J Nutr. 1994 Jul;124(7):1060-4.
27. Crit Rev Food Sci Nutr. 2006;46(8):621-8.
28. Magnes Res. 1993 Jun;6(2):155-63.
29. J Reprod Med. 1990 May;35(5):503-7.
30. J Clin Endocrinol Metab. 2010 Jun;95(6):2630-3.
31. Am J Clin Nutr. 1995 Mar;61(3 Suppl):638S-45S.
32. Ann Nutr Metab. 2009;54(3):218-26
33. Toxic Sci. 2006 Jul;92(1):286-94
34. PDR for Nutritional Supplements, 1st ed. Montvale, NJ: Medical Economics Co.; 2001:288-95.
35. J Nutr Sci Vitaminol (Tokyo). 1999 Oct;45(5):509-17.
36. Methods Find Exp Clin Pharmacol. 1995 Sep;17(7):437-42.
37. Scand J Gastroenterol. 2010;45(2):133-8.
38. Osteoporos Int. 2009 Jul;20(7):1175-82.
39. Congest Heart Fail. 2006 Jan-Feb;12(1):9-13.
40. Br J Sports Med. 2006 Sep;40(9): 773-8.
41. Front Biosci. 2004 May 1;9:1278-93.
42. South Med J. 2001 Dec;94(12):1195-201.
43. PDR for Nutritional Supplements, 1st ed. Montvale, NJ: Medical Economics Co.; 2001:60-3.
44. Environ Health Perspect. 1994 Nov;102 Suppl 7:59-63.
45. Bone. 2003 Feb;32(2):127-35.
46. Magnes Res. 1993 Sep;6(3):247-9.
47. Biol Trace Elem Res. 2009 Jun;128(3):239-47.
48. Environ Health Perspect. 1994 Nov;102 Suppl 7:83-5.
49. Crit Rev Food Sci Nutr. 2003;43(2):219-31.
50. Prog Food Nutr Sci. 1993 Oct-Dec;17(4):331-49.
51. Nutr Rev. 2008 Apr;66(4):183-91.
52. J Bone Miner Metab. 2001;19(3):146-9.
53. Osteoporos Int. 2007 Jul;18(7):963-72.,
54. J Bone Miner Res. 2007 Apr;22(4):509-19.
55. Natural Vitamin K2 as Menaquinone-7. Monograph April 2006
56. Blood. 2007 Apr 15;109(8):3279-83.
57. Vitam Horm. 2008;78:393-416.
58. Curr Drug Saf. 2006 Jan;1(1):87-97.
59. Prog Food Nutr Sci. 1992 Oct-Dec;16(4):307-43
60. Valensa. (Data on File.) 2011.
61. Altern Med Rev. 2010 Apr;15(1):84-6.
62. J Am Coll Nutr. 2007 Feb;26(1):39-48.
63. Curr Med Chem. 2009;16(14):1718-45.
64. Curr Rheumatol Rep. 2003 Feb;5(1):7-14.
65. Nutr J. 2008;7:3.
66. Am J Phys Med Rehabil. 2005 Apr;84(4):278-83; quiz 84, 93.
67. World J Gastroenterol. 2007 Feb 14;13(6):945-9.
68. J Nutr Biochem. 2010 May;21(5):381-9.
69. Wien Med Wochenschr. 2002;152(15-16):373-8.
70. J Ethnopharmacol. 2006 Sep 19;107(2):249-53.
71. Mol Cell Biochem. 2011 Aug;354(1-2):189-97.
72. Mol Nutr Foods Res 2006 Feb;50(2):115-22.
73. Adv Ther. 2011 Oct;28(10):894-906.
74. Acta Vet Scand. 2008 Nov 7;50:45.
75. Nutr J. 2008 Oct 27;7:31.
76. Miljkovic D (1999) Boron and carbohydrate complexes and uses thereof. U.S. Patent # 5,962,049.
77. Miljkovic ND, Miljkovic DA, Ercegan GM (2002) Osteoarthritis and Calcium Fructoborate Supplementation: An Open-Label Study. FutureCeuticals Internal Study.
78. Available at: http://www.futureceuticals.com/pdfs/r_d_section/fc_research_page/by_product/fruitex_b/5._fruitexb_increases_bone_density-r_d.pdf Accessed December 17, 2012.
79. Int J Med Sci. 2009;6(6):312-21.
80. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443-6.
81. Int Immunopharmacol. 2011 Jan;11(1):12-8.
82. Int J Clin Pharmacol Res. 2002;22(3-4):101-10.
83. Immunol Rev. 2005;206:232-59.
84. J Vet Pharmacol Ther. 2005 Aug;28(4):385-90.
85. J Vet Pharmacol Ther. 2007 Jun;30(3):275-8.
86. Toxicol Mech Methods. 2007;17(4):189-96.
87. J Anim Physiol Anim Nutr (Berl). Epub 2011 May 30.
88. J Vet Pharmacol Ther. 2009 Dec;32(6):577-84.
89. http://www.koact.net/index.php?id=science Accessed December 17, 2012.
90. BMJ. 2005 Jun 18;330(7505):1400-1.
91. J Clin Endocrinol Metab. 2005 May;90(5):2816-22.
92. Joint Bone Spine. 2004 Jul;71(4):261-3.
93. Int Immunopharmacol. 2009 Mar;9(3):313-8.
94. Clin Rheumatol. 2009 Aug;28(8):931-463.
95. Chandran B, Chakkiath VK, Thomas SPO. A multicentre, randomized, controlled human clinical study to assess the efficacy and safety of Biocurcumax (BCM-95®) compared to diclofenac sodium. Submitted for publication. 2009.
96. Indian J Pharm Sci. 2008 Jul-Aug;70(4):445-9.
97. http://www.docstoc.com/docs/57587485/Nutraceutical-Composition-Comprising-Soluble-Keratin-Or-Derivative-Thereof---Patent-7579317 accessed December 18, 2012.
98. Biol Pharm Bull. 2003 Sep;26(9):1283-8.
99. Life Sci. 2003 Jun 13;73(4):471-85.
100. Mol Pharmacol. 2006 Jun;69(6):1783-90.
101. Mapo Pain Clinic, Seoul. November 2001. Scigenic Co., Ltd. Unpublished study report obtained from manufacturer.
102. J Agric Food Chem. 2008 Nov 26;56(22):10582-93.
103. Nutr J. 2008 Jan 21;7:3.
104. Curr Med Res Opin. 2008 May;24(5):1485-96.
105. Int J Food Sci Nutr. 2009;60 Suppl 2:99-113.
106. Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1365-70.
107. Clin Immunol. 2008 Jul;128(1):66-74. Epub 2008 May 14.
108. Evid Based Complement Alternat Med. 2004 Dec;1(3):251-7.
109. Clin Exp Rheumatol. 2006 Jan-Feb;24(1):25-30.
110. Clin Rheumatol. 2004 Oct;23(5):410-5.
111. Arthritis Res Ther. 2007;9(6):R117.
112. Evid Based Complement Alternat Med. 2007 Jun;4(2):219-24.
113. N Engl J Med. 2006 Feb 23;354(8):795-808.
114. Eksp Klin Farmakol. 2002 Nov-Dec;65(6):67-9.
115. Fortschr Med. 1980 Jun 5;98(21):801-6.
116. Osteoarthritis Cartilage. 2003 Jun;11(6):424-32.
117. Osteoarthritis Cartilage. 1998 Nov;6(6):427-34.
118. Rheumatol Int. 2007 Jan;27(3):213-8.
119. Arthritis Rheum. 2007 Feb;56(2):555-67.
|
/001203-350x350.jpg)
/001824-270x200.jpg "Life Extension Advanced Olive Leaf Vascular Support with Celery Seed Extract, 60 vege caps")
/001725-270x200.jpg "Life Extension Bone Strength Collagen Formula, 120 capsules")
/001603-270x200.jpg "Life Extension Neuro-Mag™ Magnesium L-Threonate, 90 vege caps")
Social Login